Novartis Zelnorm sNDA For Chronic Constipation To Be Reviewed By Cmte.

New indication for intestinal bowel syndrome drug Zelnorm will be considered by FDA’s Gastrointestinal Drugs Advisory Committee July 14. Severe diarrhea and ischemic colitis associated with Zelnorm use are likely to be discussed.